Microsoft word - patient updates
Hi everyone, I hope this finds you well! I attended the North American Menopause Society(NAMS) annual conference in Dallas from Oct. 2nd – 6th and wanted to share just a few bits ofinformation with you…
First and foremost…medicine is an art, not an exact science! The good news is that each yearnew menopause information is evolving, although it is clear that a total understanding ofmenopausal issues is still in its infancy.
The goal of the conference was to support informed choices by you our patients. We asclinicians are called on to provide information that is accurate, current and useful to you. Here ismy best shot to update you!
(patch, cream, gel, vaginal ring) remains the estrogen of choice….there
is not an increased risk of stroke as there is with oral, and it has several other positive benefits. It
is best when started less than 10 years past menopause. There is less heart disease, osteoporosis,
diabetes, colon cancer and overall mortality in users.
For women using estrogen for greater than 20 years it is felt there is no evidence that says sheshould stop. It can be given in the dose (lowest) that is needed for a woman’s symptoms andbenefits.
: There was very little discussion of Progestogens
(umbrella term) except;
There has been much research on Provera
…it is not recommended (as in
PremPro…Premarin and Provera)
There has not been a lot of research on Progesterone
, and until that research is
done…which is highly unlikely…the scientific community hesitates to give many
opinions. It is preferred over other progestogens!
levels decrease most dramatically in women between ages 20 and 40, and then
seem to level off. Transdermal testosterone can be beneficial to premenopausal and naturally
menopausal women. It helps increase genital blood flow and vaginal secretions, increase sexual
response, improve muscle mass, and improve sense of well being.
numbers went down in the estrogen only arm of the WHI (Women’s Health
Initiative), but numbers went up in the Premarin/Provera arm. Does this implicate Provera?
Possibly, but no proof.
The #’s of breast cancers has gone down since the WHI stopped and many women went offestrogen, is that the reason? Possible explanations…1) mammograms also went down since the
study stopped; 2) it is far too soon to make any such statements for when a breast cancer is
diagnosed it has been percolating in that breast for a minimum of 6 - more like 8-10 years; 3)
hormones do not initiate breast cancer but they do promote its growth.so with the stopping of
estrogen the growth of the cancers is slowed way down meaning it will take longer to be
diagnosed. In approx. 2008 it is thought that we will have a clearer picture as experts continue to
look at the data. The thinking now is 'not to worry'. Re Osteoporosis
…Vitamin D may be an even more important player than Calcium. It is being
suggested that we take 1000iu daily up to age 60 to 65, and thereafter 2000iu per day. Soon
bone density machines will be programmed to accept data from each patient that will more
accurately identify women whose overall risk factors call for treatment with the medications that
improve bone mass.
Re Heart Disease
…depression and a hostile attitude are key factors associated with the risk of
developing Heart Disease.
…an Omega 3 fatty acid – EPA, DHA (1gram) daily is recommended for a healthy heart
…our goal should be 15 minutes of brisk walking each day so that we become vigorous
elderly, and productive in our old age!!!
… no difference was found in risk of heart attack after 10 years of use therefore it is not
recommended for primary prevention of heart disease in women. However, if a woman has had
a heart attack then yes…a baby ASA every other day …and after age 65, one is recommended
every other day to decrease the risk of heart attack and stroke.
OTC COMPANY NEWS Oxford Nutrascience offers better taste Oxford Nutrascience is seeking brand-own- bald and another ex-Boots man,Marcelo Bravo. ers worldwide to license its delivery sys-tems that use prebiotic soluble fibres to makeand healthcare product development at Boots,medicines and food supplements more pleas-while Bravo worked in new business develop-ment for the company. B
Advances in Urinary Catheter Technology Introduction stances adhere to the surface of the catheter.3 ItThe first recorded use of a urethral catheter washas been the focus of considerable study. in ancient Egypt, when papyrus reeds wereEncrustation may happen whether the urineused to artificially drain the bladder. present is infected or sterile, and is thought toSubsequently, a variet